The Company Announces Three Senior Executives in Finance, Marketing and Sales

Newport News, Va., January 6, 2020 — ivWatch today announced three new additions to its executive management team with the appointments of Teresa (Terry) Blevins as Chief Financial Officer, Erin Wendell as Chief Marketing Officer and Paul Stoddard as Vice President of Sales. These hires will continue to build and strengthen the ivWatch company and its ability to drive growth through financial expertise, strategic marketing initiatives and strong business development.

“We are thrilled to welcome Terry, Erin and Paul, three senior executives with proven track records and vision to the ivWatch team,” said Gary Warren, CEO and President of ivWatch. “Collectively, these leaders will complement our talented team at the company, enrich and advance our global presence, drive awareness in the healthcare industry and to consumers, delivering on our mission to provide safety to our patients by reducing the risks associated with IV infiltration.”

Blevins, Wendell and Stoddard will report directly to Warren and will be based out of the company’s global headquarters in Newport News. As part of the executive team, Blevins will be responsible for the accounting, finance and supply chain functions. Wendell will lead the strategic vision and direction for ivWatch’s global branding and messaging, digital presence, internal and external communications and experiential marketing. Stoddard will oversee the United States sales and clinical divisions, driving growth and new partnerships, revenue and profitability for the ivWatch company.

Terry Blevins, Chief Financial Officer
Blevins joins the company with a strong financial and operations background in large and small businesses from both an internal leadership and external consulting perspective. Blevins has successfully led corporations and their strategic financial planning for over 30 years and she most recently served as the Interim CFO at Psionic Lidar.

Prior to that, she served as CFO of Landmark Media Enterprises, a diverse global holding company of media and technology assets that included The Weather Channel and Norfolk’s metro newspaper, The Virginian Pilot. She has held additional leadership roles in manufacturing with several Fortune 500 companies such as General Electric and Borg Warner.

Blevins is a CPA and has a B.S. in Accounting and a Master’s in Accounting and Information Systems from Virginia Tech in Blacksburg, Va.

Erin Wendell, Chief Marketing Officer
As a member of the executive team, Wendell will lead all aspects of the company’s global brand marketing strategy. Wendell has successfully built global marketing communications, directives, initiatives and experiences for nearly 15 years. She most recently served as the Senior Director of Global Communications at Under Armour. At Under Armour, she played a critical role in growing the communications function from its inception, driving brand awareness, executing entries into global markets, launching major campaigns and products and establishing best in class media and employee communications practices.

Wendell has a B.A. degree in Economics and Business from Randolph-Macon College in Richmond, Va.

Paul Stoddard, Vice President of Sales
Stoddard joins the ivWatch team with a robust background in healthcare sales with over 30 years of experience. Most recently he spent the last 20 years at Phillips Healthcare leading a variety of sales teams in the Ultrasound and Emergency Care & Resuscitation divisions. He comes to ivWatch as a leading dynamic national sales manager with a strong reputation of cultivating new and existing relationships and pioneering brands into their next chapter of growth.

Prior to his tenure at Phillips Healthcare, Stoddard served in a variety of leadership roles at Laerdal Medical Corporation, Pace Tech Inc. and Cardiotronics Inc. Stoddard began his career at First Medical Device Corporation and has a B.S. in Business Administration and Management from York College in York, Pa.

As strategic leaders of ivWatch, each of these executives will partner with all cross functional divisions within the company to grow the business domestically and around the globe.

About ivWatch
ivWatch, LLC is a medical biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is pioneering the use of optical sensors to detect adverse IV events early to minimize the risk of injury caused by infiltrations and extravasations. By using this technology, clinicians can leverage continuous monitoring to help identify infiltrations as early as possible. Our innovative monitored IV solutions are backed by decades of clinical research and device development. To learn more, follow us on Twitter @ivWatch or Facebook @ivWatchLLC, or visit www.ivwatch.com.

ivWatch is pleased to sponsor the work of myIV.com, an online resource dedicated to empowering visitors with information on all things IV, simplified.

ivWatch Logo White

Download Our Whitepaper

Thank you for requesting more information about the ivWatch Clinical Studies. The ivWatch Model 400 is the only continuous monitoring device for the early detection of IV infiltration and extravasation events.

[fc id='6'][/fc]

You have Successfully Subscribed!

Pin It on Pinterest